molt 3 (ATCC)


Structured Review
Molt 3, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 3 (ATCC)


Structured Review
Molt 3, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 3 (ATCC)


Structured Review
Molt 3, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 3 cells (ATCC)


Structured Review

Molt 3 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3 cells/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4"
Article Title: AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4
Journal: mBio
doi: 10.1128/mbio.03382-22

Figure Legend Snippet: Nef strongly enhances HIV-1 replication in MOLT-3 cells lacking LCK. (A) LCK expression in parental MOLT-3 cells and in LCK KO clones analyzed by Western blotting. (B) CD4 surface levels on the same cells analyzed by flow cytometry. (C) Western blots showing the effects of Nef on HIV-1 replication in parental MOLT-3 cells and in LCK KO clones. The cells were infected with equal amounts (0.2 ng p24/mL) of Nef + or Nef − HIV-1 NL4-3 , and cell lysates were examined with anti-CA and anti-actin 10 days after infection. (D) Virus replication in the same cultures monitored by measuring p24 accumulation in the supernatants over time.
Techniques Used: Expressing, Clone Assay, Western Blot, Flow Cytometry, Infection

Figure Legend Snippet: Nef can strongly enhance HIV-1 replication in cells lacking PAK2. (A) PAK2 expression in parental and in PAK2 KO MOLT-3 cells analyzed by Western blotting. (B) CD4 surface levels on the same cells analyzed by flow cytometry. (C) Western blots showing that the effects of Nef on HIV-1 replication in parental and in PAK2 KO MOLT-3 cells are comparable. The cells were infected with 0.2 ng p24/mL of Nef + or Nef − HIV-1 NL4-3 , and cell lysates were analyzed as in
Techniques Used: Expressing, Western Blot, Flow Cytometry, Infection

Figure Legend Snippet: Nef can fully support HIV-1 replication in the absence of all group I PAKs. (A) Expression of group I PAK mRNAs in MOLT-3 cells quantified by transcriptome sequencing (RNA-seq) as fragments per kilobase of transcript per million mapped reads (FPKM). (B) Expression of PAK1 and PAK2 in parental MOLT-3 cells and in PAK1/PAK2 double-KO clones analyzed by Western blotting. (C) CD4 surface levels on the same cells analyzed by flow cytometry. (D and E) Replication of Nef + and Nef − HIV-1 NL4-3 in the same cells after infection with 0.2 ng/mL p24, monitored by Western blotting of cell lysates with anti-CA (D) and by measuring p24 accumulation in the supernatants (E).
Techniques Used: Expressing, Sequencing, RNA Sequencing Assay, Clone Assay, Western Blot, Flow Cytometry, Infection

Figure Legend Snippet: Nef remains required for efficient HIV-1 replication in MOLT-3 cells lacking SERINCs and Nef-sensitive CD4. (A) CD4 surface levels on parental MOLT-3 cells and on M3 triple-KO (SERINC3/SERINC5/CD4 KO) cells analyzed by flow cytometry. (B) CD4 surface levels on M3-triple-KO/CD4 and M3 triple-KO/CD4 ΔCT cells stably transduced with empty MSCVpuro (vector) or with a version expressing Nef LAI . (C) Relative infectivities of Nef + and Nef − HIV-1 NL4-3 virions produced in M3 triple-KO/CD4 ΔCT cells measured using MOLT-3/ZsGreen reporter cells. Data are mean of three experiments with SD. (D) Replication of Nef + and Nef − HIV-1 NL4-3 in M3 triple-KO/CD4 ΔCT cells. The cells were infected with 0.2 ng p24/mL, and cell lysates were examined by Western blotting with anti-CA and anti-actin on day 8 postinfection (p.i.). (E) Replication of Nef + and Nef − versions of the R5-tropic NL-JRFL and NL-ZM109 viruses in M3 triple-KO/CD4 ΔCT /CCR5 cells infected with 0.2 ng p24/mL, monitored by measuring p24 accumulation in the supernatants. (F) Replication of Nef + and Nef − HIV-1 NL4-3 in heterokaryons formed between M3 triple-KO/CD4 ΔCT (GFP 8-11 ) cells and JTAg double-KO(GFP 1-7 ) cells transiently expressing the HN and F proteins of NDV. GFP-positive cells were sorted by FACS and infected with 5 ng p24/mL. Virus replication was monitored by measuring p24 accumulation in the supernatants.
Techniques Used: Flow Cytometry, Stable Transfection, Transduction, Plasmid Preparation, Expressing, Produced, Infection, Western Blot

Figure Legend Snippet: Replication of Nef mutants in M3 triple-KO/CD4 ΔCT cells lacking SERINCs and Nef-sensitive CD4. (A) Effect of a mutation (WL57,58AA) reported to disrupt binding of Nef to the cytoplasmic domain of CD4. (B) Effects of mutations that disrupt AP-2 binding. (C) Effects of mutations in a conserved diacidic motif that is specifically required for binding to AP-2 but not AP-1 or AP-3. Of note, AP-2 binding is unaffected by the conservative D174E substitution but is impaired by the equally conservative D175E substitution . (D) Side-by-side comparison of the abilities of the Nef mutants to spread in parental MOLT-3 cells and in M3 triple-KO/CD4 ΔCT cells. The cells were infected with WT (Nef + ) HIV-1 NL4-3 or with the indicated Nef mutants (0.2 ng p24/mL), and virus replication was monitored by measuring p24 accumulation in the supernatants (A to C) or by Western blotting of cell lysates with anti-CA (D). The virus replication curves are all from the same experiment.
Techniques Used: Mutagenesis, Binding Assay, Infection, Western Blot
molt 3 (ATCC)


Structured Review

Molt 3, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Low Intraprostatic DHT Promotes the Infiltration of CD8+ T Cells in BPH Tissues via Modulation of CCL5 Secretion"
Article Title: Low Intraprostatic DHT Promotes the Infiltration of CD8+ T Cells in BPH Tissues via Modulation of CCL5 Secretion
Journal: Mediators of Inflammation
doi: 10.1155/2014/397815

Figure Legend Snippet: CD8+ T cells migration in vitro . (a) CD8+ T cell migrated to lower chamber after 6 hrs. Scale bar: 50 μ m. (b) Data showed as the percentage of migrated cell number in total cell number (mean ± SEM). * P < 0.000. ( t -test). (c) The migration of molt-3 cells to BPH-1 cells with/without charcoal medium treatment in the lower chamber. Data presented as the average cell numbers (mean ± SEM). * P = 0.026. (ANOVA and Newman-Keuls test).
Techniques Used: Migration, In Vitro
molt 3 (ATCC)


Structured Review
Molt 3, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 3 cell lines (ATCC)


Structured Review
Molt 3 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3 cell lines/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 3 cells (ATCC)


Structured Review
Molt 3 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3 cells/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt (ATCC)


Structured Review
Molt, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 3 (ATCC)


Structured Review

Molt 3, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Synergistic Apoptosis-Inducing Antileukemic Effects of Arsenic Trioxide and Mucuna macrocarpa Stem Extract in Human Leukemic Cells via a Reactive Oxygen Species-Dependent Mechanism"
Article Title: Synergistic Apoptosis-Inducing Antileukemic Effects of Arsenic Trioxide and Mucuna macrocarpa Stem Extract in Human Leukemic Cells via a Reactive Oxygen Species-Dependent Mechanism
Journal: Evidence-based Complementary and Alternative Medicine : eCAM
doi: 10.1155/2012/921430

Figure Legend Snippet: Antiproliferative effects of combined application of arsenic trioxide (ATO) and crude methanolic extract of Mucuna macrocarpa (CMEMM) on human leukemia cells. HL-60, Jurkat, or Molt-3 cells (1 × 10 5 cells/mL) were seeded into 6-well plates and exposed to 0, 2.5, or 5 μ M ATO alone or together with 0, 25, 50, or 75 μ g/mL CMEMM for 24 and 48 h. Vehicle control cells were treated with 0.1% DMSO in medium. The percentages of cell growth were measured by the trypan blue exclusion assay and calculated by comparing the cells number with that of the vehicle controls. Each value represents the mean ± S.E. of duplicate cultures from three independent experiments. * P < 0.05, ** P < 0.01 indicate significant difference from the respective control value.
Techniques Used: Trypan Blue Exclusion Assay

Figure Legend Snippet: Nuclear morphological changes induced by arsenic trioxide (ATO) and/or crude methanolic extract of Mucuna macrocarpa (CMEMM). HL-60, Jurkat, or Molt-3 cells (1 × 10 5 cells/mL) were treated with 0.1% DMSO (control), 2.5 μ M ATO, 50 μ g/mL CMEMM, or 2.5 μ M ATO plus 50 μ g/mL CMEMM. After 24 or 48 h of incubation, cells were washed with PBS and collected on microscope slides by cytospin. The nuclei were stained with 2.5 μ g/mL DAPI. Arrows indicate apoptotic bodies of nuclear fragmentation. Magnification × 200.
Techniques Used: Incubation, Microscopy, Staining
molt 3 cells (ATCC)


Structured Review

Molt 3 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3 cells/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Erythrocyte Inosine Triphosphatase Activity Is Decreased in HIV-Seropositive Individuals"
Article Title: Erythrocyte Inosine Triphosphatase Activity Is Decreased in HIV-Seropositive Individuals
Journal: PLoS ONE
doi: 10.1371/journal.pone.0030175

Figure Legend Snippet: A: The effect of the addition of nucleoside analogues (10 µM) on the activity of hrITPase (2 µg). B: ITPase activity of MOLT-3 cells after 18 hr of incubation with 10 µM of the nucleoside analogues indicated; ziduvodine (AZT), zalcitabine (ddC), stavudine (d4T), dideoxyadenosine (ddA), didanosine (ddI), tenofovir (TDF), abacavir (ABC), lamivudine (3TC), 6-mercaptopurine (6MP), cytarabine (araC), gemcitabine (dFdC)* p <0.05.
Techniques Used: Activity Assay, Incubation